$AUTL News

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

Autolus Therapeutics PLC (AUTL) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...

Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript

Autolus Therapeutics plc 2026 Q1 - Results - Earnings Call Presentation

Autolus Therapeutics Q1 Earnings Call Highlights

HC Wainwright & Co. Maintains Buy on Autolus Therapeutics, Raises Price Target to $10

Autolus Therapeutics (NASDAQ:AUTL) Posts Inline Q1 Results with First Positive Gross Margin, but Full-Year Guidance Slightly Below Consensus

Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Autolus Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript

Autolus Therapeutics Sees FY2026 Sales $120.000M-$135.000M vs $130.062M Est

Autolus Therapeutics Q1 EPS $(0.27), Inline, Sales $26.218M Beat $26.160M Estimate

Autolus Therapeutics (AUTL) to Cut Workforce by 13% While Doubling 2026 Manufacturing Capacity

Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026

How The Narrative On Autolus Therapeutics (AUTL) Is Shifting After Analyst Target Resets

Is Autolus Therapeutics (AUTL) One of the Best Biotech Penny Stocks to Buy in 2026?

Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction

Autolus Therapeutics Plans To Cut Workforce By ~13% As Part Of Initiative To Enhance Operational Efficiency, Lower Operating Expenses

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

How The Autolus Therapeutics (AUTL) Narrative Is Shifting With Recalibrated Targets And Fair Value

Autolus Therapeutics Eyes CAR-T Edge With AUCATZYL Safety, Expands Centers, Sees Margin Turnaround